CRVO
Price
$2.25
Change
+$0.02 (+0.90%)
Updated
Dec 20, 04:59 PM (EDT)
VKTX
Price
$42.14
Change
-$0.11 (-0.26%)
Updated
Dec 23, 10:42 AM (EDT)
44 days until earnings call
Ad is loading...

CRVO vs VKTX

Header iconCRVO vs VKTX Comparison
Open Charts CRVO vs VKTXBanner chart's image
CervoMed
Price$2.25
Change+$0.02 (+0.90%)
Volume$8.1K
CapitalizationN/A
Viking Therapeutics
Price$42.14
Change-$0.11 (-0.26%)
Volume$1.6K
CapitalizationN/A
CRVO vs VKTX Comparison Chart
Loading...
CRVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRVO vs. VKTX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRVO is a Hold and VKTX is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (CRVO: $2.23 vs. VKTX: $42.25)
Brand notoriety: CRVO and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRVO: 75% vs. VKTX: 177%
Market capitalization -- CRVO: $18.41M vs. VKTX: $4.71B
CRVO [@Biotechnology] is valued at $18.41M. VKTX’s [@Biotechnology] market capitalization is $4.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRVO’s FA Score shows that 1 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • CRVO’s FA Score: 1 green, 4 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, VKTX is a better buy in the long-term than CRVO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRVO’s TA Score shows that 4 TA indicator(s) are bullish while VKTX’s TA Score has 4 bullish TA indicator(s).

  • CRVO’s TA Score: 4 bullish, 4 bearish.
  • VKTX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CRVO is a better buy in the short-term than VKTX.

Price Growth

CRVO (@Biotechnology) experienced а +17.37% price change this week, while VKTX (@Biotechnology) price change was -10.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

CRVO is expected to report earnings on Nov 13, 2023.

VKTX is expected to report earnings on Feb 05, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($4.71B) has a higher market cap than CRVO($18.4M). VKTX YTD gains are higher at: 127.028 vs. CRVO (-70.773). CRVO has higher annual earnings (EBITDA): -7.83M vs. VKTX (-133.66M). VKTX has more cash in the bank: 930M vs. CRVO (46.7M). CRVO has less debt than VKTX: CRVO (0) vs VKTX (1.24M). CRVO (0) and VKTX (0) have equivalent revenues.
CRVOVKTXCRVO / VKTX
Capitalization18.4M4.71B0%
EBITDA-7.83M-133.66M6%
Gain YTD-70.773127.028-56%
P/E Ratio4.73N/A-
Revenue00-
Total Cash46.7M930M5%
Total Debt01.24M-
FUNDAMENTALS RATINGS
CRVO vs VKTX: Fundamental Ratings
CRVO
VKTX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
54
Fair valued
PROFIT vs RISK RATING
1..100
10048
SMR RATING
1..100
9792
PRICE GROWTH RATING
1..100
9859
P/E GROWTH RATING
1..100
71100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRVO's Valuation (32) in the Biotechnology industry is in the same range as VKTX (54). This means that CRVO’s stock grew similarly to VKTX’s over the last 12 months.

VKTX's Profit vs Risk Rating (48) in the Biotechnology industry is somewhat better than the same rating for CRVO (100). This means that VKTX’s stock grew somewhat faster than CRVO’s over the last 12 months.

VKTX's SMR Rating (92) in the Biotechnology industry is in the same range as CRVO (97). This means that VKTX’s stock grew similarly to CRVO’s over the last 12 months.

VKTX's Price Growth Rating (59) in the Biotechnology industry is somewhat better than the same rating for CRVO (98). This means that VKTX’s stock grew somewhat faster than CRVO’s over the last 12 months.

CRVO's P/E Growth Rating (71) in the Biotechnology industry is in the same range as VKTX (100). This means that CRVO’s stock grew similarly to VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRVOVKTX
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
87%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
85%
View a ticker or compare two or three
Ad is loading...
CRVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GSM3.870.10
+2.73%
Ferroglobe PLC
BXMT18.150.42
+2.37%
Blackstone Mortgage Trust
TSQ9.720.06
+0.62%
Townsquare Media
NOK4.43N/A
N/A
Nokia Corp
PAVM0.58-0.02
-3.82%
PAVmed

CRVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRVO has been loosely correlated with TCRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CRVO jumps, then TCRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVO
1D Price
Change %
CRVO100%
N/A
TCRX - CRVO
39%
Loosely correlated
+1.37%
VIRX - CRVO
28%
Poorly correlated
-1.87%
VKTX - CRVO
27%
Poorly correlated
+1.83%
NKTR - CRVO
27%
Poorly correlated
-1.35%
AVXL - CRVO
27%
Poorly correlated
+1.89%
More